Voluntary Recall Issued on Excedrin, Bufferin, NoDoz and Gas-X

Drugmaker Novartis is voluntarily recalling bottles of Excedrin, NoDoz, Gas-X-Prevention and Bufferin in the U.S. because they may contain stray pills or broken or chipped tablets.

Select bottles of these over the counter medications are under recall after an internal review and complaints of "broken gelcaps, chipped tablets and inconsistent bottle packaging line clearance practices" where inspectors could not rule out the possibility of pills getting into the wrong bottles, according to a release from the company.

The company has not received any complaints about the possible mix-ups or broken tablets and says there have been no reports of health issues leading to the recall.

Here are all medications on the recall list:

• All Bufferin products expiring Dec. 20, 2013 or earlier, including regular strength tablets, low dose tablets and extra-strength tablets.
• All Gas-X Prevention products expiring Dec. 20, 2013 or earlier.
• All NoDoz products expiring Dec. 20, 2014 or earlier.
• All of the following Excedrin products expiring Dec. 20, 2014 or earlier: Excedrin Extra Strength Caplets, Excedrin Extra Strength Express Gel Caplets, Excedrin Extra Strength Gel Caplets, Excedrin Extra Strength Tablets, Excedrin Back & Body Caplets, Excedrin Sinus Headache Caplets, Excedrin Migraine Caplets, Excedrin Migraine Gel Tablets, Excedrin Migraine Tablets, Excedrin Menstrual Complete Express Gel Caplets, Excedrin PM Caplets, Excedrin PM Express Gel Caplets, Excedrin PM Tablets, Excedrin Tension Headache Caplets, Excedrin Tension Headache Express Gel Caplets, Excedrin Tension Headache Gel Tablets

Novartis is asking that all medications on the list either be destroyed or returned. Visit the Novartis website for a product return and reimbursement form.